23G 4mm Sclerotherapy Endoscopic Injection Needle with 2300mm Working Length

Name: 23G 4mm Sclerotherapy Endoscopic Injection Needle with 2300mm Working Length
Brand: Jiangxi ZhuoRuiHua Medical Instrument Co., Ltd.
SKU: 1938417835

Jiangxi, ChinaJiangxi ZhuoRuiHua Medical Instrument Co., Ltd.

US$9.00

10-99 Pieces

US$6.00

100-999 Pieces

US$5.00

1,000+ Pieces

Sample price:US$10.00/piece.Request sample

Product profile

Customization

Available

Type

Surgical Supplies Materials

Ethylene Oxide Sterilization

Model NO.

ZRH-PN

Quality Guarantee Period

Two Years

Group

Adult

Logo Printing

With Logo Printing

Model No.

Zrh-Pn

Working Length

1800mm 2300mm

Needle Length

4-6mm

Needle Gauge

21g 23G 25g

Endoscope Channel

2.0mm 2.8mm

Application Area

Endoscopy, Colonoscopy & Gastroenterology

Color

White&Blue

Customized

OEM

Certificate

CE ISO

Sampeles

Free

Transport Package

Carton

Specification

21g 23g 25g

Trademark

ZRHMED

Origin

China

HS Code

9018909010

Production Capacity

500000PCS/Year

Company profile

High Repeat Buyers ChoiceExperienced TeamExhibition ExperienceStandardized quality control

Jiangxi ZhuoRuiHua Medical Instrument Co., Ltd.

Jiangxi, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 5 Years CertifiedNearest Port: Ningbo Port, Shanghai PortAverage Response Time: ≤15h

AI-Powered supplier vetting

SummaryThe supplier operates in medical-device and related food and hygiene product categories under stated licensed business scopes. It demonstrates documented procedures for quality assurance, corrective and preventive actions, complaint handling, finished-product inspection, and supplier-service assessment. It offers 3D design, ODM, OEM, and multiple customization modes, but reported no new products in the past year and has no SDK availability. Production-related evidence includes two production lines and 11–20 quality-control staff, while no valid manufacturing-capacity contract with affiliated subcontractors was reported. Export experience is stated as five years, with 51%–70% of sales from exports and self-operated import/export rights. The supplier lacks in-stock capacity, overseas warehouses, overseas showrooms, and overseas agents or branches. Financial records are identified for 2021–2023, but their performance is not provided. Customer-case evidence is limited to OEM service for well-known brands and...

Supplier typeThe stated licensed scope covers production and operation of Class II and Class III medical devices, hygiene and disposable medical products, and food-related activities. The company describes itself as focused on endoscopic diagnosis and treatment consumables, indicating a medical-device manufacturer and supplier orientation.

After-Sales capabilityDocumented procedures and records exist for customer complaints and corrective and preventive actions, supporting a formal service-response process. However, the supplier reports no overseas agents or branches, no overseas warehouse, no overseas showroom, and no in-stock service capacity, limiting evidence of localized after-sales support.

Production capacityProduction capability is supported by two production lines, 11–20 quality-control staff, documented finished-product inspection instructions, and quality-control assurance. A material limitation is the absence of a valid contract between the factory and affiliated subcontractors for manufacturing capacity, while no in-stock capacity is also reported.

Customization capabilityThe supplier explicitly provides customization from samples, designs, full customization, minor customization, and flexible customization, together with 3D design, ODM, and OEM services. These statements directly support broad customization capability.

Client casesThe supplier states that it provides OEM services for well-known brands and participated in Expomed Eurasia 2022. These are direct indicators of market engagement, but the slices do not provide customer names, project details, volumes, outcomes, or references, so the depth of its customer case history cannot be fully assessed.